Free, from ChinaClarity: independent of Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC. Facts below come from the public sources on this page. Ratings and invented prices are not shown.
Not ready to pay?
Get the 15 questions to ask Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC before you pay a deposit — free, and printable.
Read the 15 questionsAll in the $149 report, each with its source and the date we checked. See a sample report
ChinaClarity does not publish patient star ratings or review counts. If a public source is silent, this page says so.
No review chart is published for this hospital.
Ask about language, a written price before any deposit, and whether the report and imaging files come home with you. Those are questions, not a score.
English support is a sourced field on the summary above, or it is unknown.
Review charts that were not tied to a checked corpus were removed on 19 Oct 2026.
Airports are named below. This page does not quote a distance, a taxi time, or a flight duration. Check those on the day.
This page does not quote a distance, a taxi time, or a flight duration.
This page does not quote a distance, a taxi time, or a flight duration.
This page does not quote a distance, a taxi time, or a flight duration.
Illustrative timetable; Beijing airports plus intercity rail are usually the practical route. The full report covers visa, the rail transfer and directions to each Tianjin campus.
Free on this page: the register note, what the hospital publishes, and what we could not confirm. The USD 149 report is a pre-order. Payment is not open, and this page does not charge you.
The Institute of Hematology & Blood Diseases Hospital is a Grade 3A specialist hospital in Tianjin, directly under the National Health Commission and part of the Chinese Academy of Medical Sciences and Peking Union Medical College; its official site describes it as China's largest national-level, research-oriented institution dedicated to blood diseases (official site, checked 15 Oct 2026).
It was founded in 1957 by Professor Deng Jiadong, regarded as a founder of haematology in China. After relocating to Sichuan in the 1970s, the institute moved back to Tianjin in 1982.(derived context)
Its official centre-introduction page describes a 767-bed specialist hospital organised into 12 disease- and function-based clinical centres, reporting more than 200,000 visits for difficult and severe blood-disease cases each year. The official English site names centres for red blood cell disorders (including severe aplastic anaemia), leukaemia, thrombosis and haemostasis (including haemophilia), stem-cell transplantation, lymphoma and myeloma, MDS/MPN, paediatric haematology and immune cellular therapy.(derived context)
The International Medical Center opened in August 2025 on the 4th floor of Building 1 at the Tuanbo campus, with 16 open beds. According to its official page, it admits domestic and overseas patients with all types of blood disease, with care centred on cell and gene therapy, including CAR-T and gene therapy, delivered by the institute's chief experts and centre directors.(derived context)
Medical services are charged under government-guided schedules, and the official website posts outpatient consultation-fee information and formal price notices. No all-inclusive package price for overseas patients is published; treatment through the International Medical Center is arranged and quoted case by case, so a written estimate should be requested in advance (official site, checked 15 Oct 2026).
Treatments this hospital is held for: Leukemia, lymphoma and multiple myeloma, anaemia and aplastic anaemia, bleeding and clotting disorders, MDS and MPN, paediatric haematology, haematopoietic stem cell transplantation, CAR-T and gene therapy.
All hospitals we hold in China
It is a national specialist hospital for blood diseases, covering leukaemia, lymphoma and myeloma, anaemias including severe aplastic anaemia, bleeding and clotting disorders such as haemophilia, MDS/MPN, paediatric blood diseases, stem-cell transplantation and cell and gene therapy.
It is a national clinical research centre hosted by this hospital; this is a clinical-research designation and should not be confused with a National Medical Center.
Yes: its International Medical Center opened in August 2025 and explicitly serves domestic and overseas patients at the Tuanbo campus. Contact the centre in advance, as beds are limited (16) and treatment is arranged individually.
Its official International Medical Center page states that care focuses on cell and gene therapy (CGT), including CAR-T cell therapy and gene therapy, for blood diseases.
Standard services follow government-guided prices published on the official site. No fixed overseas package is published, so the centre will quote according to the individual diagnosis and treatment plan; ask for a written quotation before travel.